Physician profile
Binh Pham
NPI 1790312619
$1,930.01
in general payments reported to CMS, 2019-2025
8 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $141 · 2023: $1,089 · 2024: $541 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,788.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $625.79 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $352.85 | 2022-2024 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Teva Pharmaceuticals USA, INC. | $291.03 | 2022-2024 | Austedo Xr, Uzedy |
| Lundbeck LLC | $227.17 | 2023-2024 | Abilify Asimtufii, Abilify Maintena |
| Axsome Therapeutics, INC. | $147.20 | 2024 | Auvelity |
| Inspire Medical Systems, INC. | $134.35 | 2025 | Inspire |
| Alkermes, INC. | $122.08 | 2024 | Lybalvi, Vivitrol |
| Biogen, INC. | $29.54 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Binh Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.